Vice President Business Development
LunOSA
Chad Andresen, MS, is a prominent leader in the neurotechnology space. With a proven track record, he has successfully guided startups from inception through early commercialization, achieving revenues of up to $50 million. A prolific innovator, Chad has authored over 47 patents and serves the biomedical engineering community as a board member of several startup companies, a prestigious adjunct professorship, and editor-in-chief of the world-renowned IEEE. Currently, he continues to spearhead business development for groundbreaking advancements in new indications through Micro-Leads spinoffs, LunOSA and ExNeuro. 2025 marks Chad's 15th year of attending NANS.
Neuromodulation for Internal Organs
Thursday, January 30, 2025
11:15 AM - 12:00 PM EST